Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience

doi:10.4254/wjh.v13.i5.584

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5757)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

434

WORD

154

HTML

1905

Figures (1-5)

199

Tables (1-4)

244

Sum=2936

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

339

Download

758

Sum=1097

Publishing Process of This Article

Item

Count

Browse

472

Download

1252

Sum=1724

May 27, 2021 (publication date) through Apr 22, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. May 27, 2021; 13(5): 584-594
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584

Full Size Figure Download Figure

Figure 4 Overall survival. The 5-year survival rate was 29.6%. There was no significant difference between survival of the angiosarcoma and undifferentiated sarcoma groups.

Citation: Kim SJ, Rhu J, Kim JM, Choi GS, Joh JW. Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience. World J Hepatol 2021; 13(5): 584-594
URL: https://www.wjgnet.com/1948-5182/full/v13/i5/584.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i5.584